Yun-Deng Wu, Hui Wan, Yun Xia, Jie Ni, Jian Li, Hui Zhang, Xiang-Yang Xu, Jun Xie
Technique Center, Jinling Pharmaceutical Company Limited, 58 Xingang Road Qixia, district, Nanjing, Jiangsu 210046, People's Republic of China.
Acta Crystallogr E Crystallogr Commun. 2025 Mar 27;81(Pt 4):341-344. doi: 10.1107/S2056989025002622. eCollection 2025 Apr 1.
The title compound,CHFN, was identified as a possible critical degradation impurity of sulindac, a therapeutic COX-2 inhibitor for rheumatoid arthritis. Single-crystal X-ray analysis revealed two conformationally slightly different mol-ecules in the asymmetric unit (' = 2), each containing an indene ring system. In the crystal structure, [100] chains formed through C-H⋯N inter-actions are connected into a tri-periodic supra-molecular structure by further C-H⋯F and C-H⋯π inter-actions through 2/ symmetry operations.
标题化合物CHFN被鉴定为舒林酸(一种用于治疗类风湿性关节炎的COX-2抑制剂)可能的关键降解杂质。单晶X射线分析表明,不对称单元(Z' = 2)中有两个构象略有不同的分子,每个分子都含有一个茚环系统。在晶体结构中,通过C-H⋯N相互作用形成的[100]链通过2/ 对称操作进一步通过C-H⋯F和C-H⋯π相互作用连接成三维超分子结构。